Date: 2014-03-04
Type of information: Collaboration agreement
Compound: drug discovery and translational medicine services, including expanded profiling and molecule testing
Company: Harlan Contract Research Services (USA) Bertin Pharma (France)
Therapeutic area: Technology - Services
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On March 4, 2014, Harlan Contract Research Services and Bertin Pharma have announced a strategic partnership to offer a comprehensive package for early drug development. Under the agreement, the companies will offer a wider range of drug discovery and translational medicine services, including expanded profiling and molecule testing, especially in the context of regulatory studies. Through the alliance, Harlan CRS will strengthen its drug discovery and translational medicine offerings utilizing Bertin Pharma’s expertise in immunology and biomarkers.
Financial terms:
Latest news:
